A stable-labeled analog of PB-22 5-Pentanoic acid metabolite, suitable for use as an internal standard in GC/MS or LC/MS synthetic cannabinoid testing applications in forensic analysis, clinical toxicology, or urine drug testing. The 5-pentanoic acid metabolite is a primary urinary biomarker of the synthetic cannabinoids PB-22 and 5-F PB-22.

For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.

A stable-labeled internal standard of PB-22 4-Hydroxypentyl metabolite, also known as the Omega minus one-OH metabolite of PB-22. The 4-Hydroxypentyl analog is the major urinary metabolite of PB-22, a synthetic analog of JWH-018. The use of PB-22 has been associated with negative side effects such as nausea, vomiting, and seizures.

For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.